Philippe Gaulard

Overview

Best Publications

• CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

  Bertrand Coiffier;Eric Lepage;Josette Briere;Raoul Herbrecht

  6642
  Citations

• Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

  P Feugier;A. Van Hoof;C. Sebban;P. Solal-Celigny

  1906
  Citations

• Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

  Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  1322
  Citations

• Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

  S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks

  829
  Citations

• Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

  Nicolas Mounier;Josette Briere;Christian Gisselbrecht;Jean-Francois Emile

  736
  Citations

• Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas

  Christian Gisselbrecht;Philippe Gaulard;Eric Lepage;Bertrand Coiffier

  683
  Citations

• The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

  Laurence de Leval;David S. Rickman;Caroline Thielen;Aurélien de Reynies

  661
  Citations

• [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

  Corinne Haioun;Emmanuel Itti;Alain Rahmouni;Pauline Brice

  632
  Citations

• Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

  Corinne Haioun;Eric Lepage;Christian Gisselbrecht;Gilles Salles

  623
  Citations

• Prognostic significance of survivin expression in diffuse large B-cell lymphomas

  Colette Adida;Corinne Haioun;Philippe Gaulard;Eric Lepage

  608
  Citations

• Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

  O Hermine;C Haioun;E Lepage;MF d'Agay

  598
  Citations

• Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

  Frédéric Peyrade;Fabrice Jardin;Catherine Thieblemont;Antoine Thyss

  584
  Citations

• IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

  Rob A. Cairns;Javeed Iqbal;François Lemonnier;Can Kucuk

  564
  Citations

• Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodgkin's Lymphoma

  Olivier Hermine;Corinne Haioun;Eric Lepage;Marie-Françoise D'Agay

  532
  Citations

• Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

  Javeed Iqbal;George Wright;Chao Wang;Andreas Rosenwald

  529
  Citations

• Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

  François Lemonnier;François Lemonnier;Lucile Couronné;Marie Parrens;Jean-Philippe Jaïs

  529
  Citations

• Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

  Karim Belhadj;Felix Reyes;Jean-Pierre Farcet;Herve Tilly

  496
  Citations

• Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus

  Panagiotis Kanavaros;Marie-Claude Lescs;Josette Brière;Marine Divine

  482
  Citations

• A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response.

  Rafaèle Tordjman;Yves Lepelletier;Valérie Lemarchandel;Marie Cambot

  420
  Citations

• Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

  Can Küçük;Bei Jiang;Xiaozhou Hu;Wenyan Zhang

  397
  Citations